Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01065987 | Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Conditions | PHASE1 | COMPLETED | 24 | — | — | Sep 1, 2001 | Nov 1, 2001 | Feb 10, 2010 | 1 | Canada |
| NCT01146028 | Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting Conditions | PHASE1 | COMPLETED | 42 | — | — | Sep 1, 2001 | Nov 1, 2001 | Jan 13, 2012 | 1 | Canada |
| Arm | Type | Description |
|---|---|---|
| Tizanidine HCl 4 mg | EXPERIMENTAL | Tizanidine HCl Tablets 4 mg, Dr.Reddy's Laboratories Limited |
| Zanaflex | ACTIVE_COMPARATOR | Zanaflex 4 mg Tablets |
| Name | Type | Description |
|---|---|---|
| Tizanidine | DRUG | Tizanidine HCl Tablets 4 mg |
Inclusion Criteria: Subjects enrolled in this study will be members of the community at large. The recruitment advertisements may be done using different media (e.g. radio, newspaper, Anapharm Inc. Web site). Subjects must meet all of the following criteria in order to be included in the study: *...